(Q39010121)

8 September 2017

title

The Host Response in Patients with Sepsis Developing Intensive Care Unit-acquired Secondary Infections (English)

1 reference

8 September 2017

0 references

1 reference

13

Tom van der Poll

1 reference

8 September 2017

9

Janneke Horn

1 reference

Peter M C Klein Klouwenberg

8 September 2017

6

object named as

Peter M C Klein Klouwenberg

1 reference

8 September 2017

10

Marcus J Schultz

1 reference

8 September 2017

7

Aeilko H Zwinderman

1 reference

8 September 2017

8

Rene Lutter

1 reference

8 September 2017

Lonneke A van Vught

1

1 reference

8 September 2017

Maryse A Wiewel

2

1 reference

8 September 2017

Arie J Hoogendijk

3

1 reference

8 September 2017

Jos F Frencken

4

1 reference

8 September 2017

Brendon P Scicluna

5

1 reference

8 September 2017

Marc M J Bonten

11

1 reference

8 September 2017

Olaf L Cremer

12

1 reference

8 September 2017

language of work or name

English

0 references

publication date

20 January 2017

1 reference

American Journal of Respiratory and Critical Care Medicine

8 September 2017

published in

1 reference

8 September 2017

volume

196

1 reference

8 September 2017

issue

4

1 reference

8 September 2017

page(s)

458-470

1 reference

Severe sepsis and septic shock

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201606-1225OC

Sepsis: a roadmap for future research

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201606-1225OC

Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201606-1225OC

Host-pathogen interactions in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201606-1225OC

Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201606-1225OC

The late phase of sepsis is characterized by an increased microbiological burden and death rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201606-1225OC

Drotrecogin alfa (activated) in adults with septic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201606-1225OC

Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201606-1225OC

Macroscopic postmortem findings in 235 surgical intensive care patients with sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201606-1225OC

Immunosuppression in patients who die of sepsis and multiple organ failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201606-1225OC

Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201606-1225OC

Incidence, Risk Factors, and Attributable Mortality of Secondary Infections in the Intensive Care Unit After Admission for Sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201606-1225OC

Immunotherapy for the Adjunctive Treatment of Sepsis: From Immunosuppression to Immunostimulation. Time for a Paradigm Change?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201606-1225OC

Interobserver agreement of Centers for Disease Control and Prevention criteria for classifying infections in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201606-1225OC

A molecular biomarker to diagnose community-acquired pneumonia on intensive care unit admission

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201606-1225OC

RETRACTED: Effects of decontamination of the oropharynx and intestinal tract on antibiotic resistance in ICUs: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201606-1225OC

2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201606-1225OC

Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201606-1225OC

The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201606-1225OC

Sepsis biomarkers: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201606-1225OC

Persistent lymphopenia after diagnosis of sepsis predicts mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201606-1225OC

Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201606-1225OC

B and T lymphocyte attenuator expression on CD4+ T-cells associates with sepsis and subsequent infections in ICU patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201606-1225OC

Persistent high level of circulating midregional-proadrenomedullin and increased risk of nosocomial infections after septic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201606-1225OC

Trauma severity scoring systems as predictors of nosocomial infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201606-1225OC

Temporal Patterns of Circulating Inflammation Biomarker Networks Differentiate Susceptibility to Nosocomial Infection Following Blunt Trauma in Humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201606-1225OC

A genomic storm in critically injured humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201606-1225OC

Persistent inflammation, immunosuppression, and catabolism syndrome after severe blunt trauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201606-1225OC

Sepsis: current dogma and new perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201606-1225OC

Nosocomial infections in adult intensive-care units

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201606-1225OC

Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201606-1225OC

10.1164/RCCM.201606-1225OC

21 January 2018

Identifiers

DOI

1 reference

8 September 2017

1 reference